INS and type 2 diabetes mellitus: Type 2 diabetes mellitus (T2DM) is characterized by progressive insulin secretion defects on the basis of insulin resistance (American Diabetes Association, 2015) and is accompanied by hyperinsulinemia, hyperglycemia, increased inflammatory mediators, advanced glycation end products and amyloid deposition.